Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial
- PMID: 18783877
- DOI: 10.1016/j.eururo.2008.08.054
Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial
Abstract
Background: Quality-of-life outcomes are important in the choice of treatment strategy for men with localized prostate cancer.
Objective: To evaluate how follow-up time, number of physical symptoms, and presence of androgen deprivation affected quality of life among men randomized to radical prostatectomy or watchful waiting.
Design, setting, and participants: The study group was composed of all 376 living men included in the Swedish part of the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) between January 1, 1989, and February 29, 1996. Quality-of-life data were collected after a mean follow-up time of 4.1 yr.
Intervention: All patients were randomly assigned to radical prostatectomy or watchful waiting. Forty-five men were androgen deprived.
Measurements: Data of specific symptoms, symptom-induced stress, sense of well-being, and self-assessed quality of life were obtained by means of a questionnaire. Psychological symptoms were assessed using seven-point visual digital scales.
Results and limitations: In analyses stratified on the basis of the numbers of physical symptoms, anxiety and depressed mood were less common, and sense of well-being and self-assessed quality of life were better throughout in the radical prostatectomy group than in the watchful waiting group. As the number of physical symptoms increased, all psychological variables became worse and more prominent in the watchful waiting group. After a follow-up time of 6-8 yr, a significant decrease in quality of life (p=0.03) was seen in the watchful waiting group. Twenty-four percent of androgen-deprived patients assigned to watchful waiting reported high self-assessed quality of life compared with 60% in the radical prostatectomy group. Eighty-eight percent of patients had clinically detected tumors.
Conclusions: Androgen deprivation negatively affected self-assessed quality of life in men assigned to watchful waiting. The number of physical symptoms was associated with the level of quality of life. Quality of life was lower with longer follow-up time in both groups and was statistically significant in the watchful waiting group (p=0.03).
Comment in
-
Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.Eur Urol. 2009 Feb;55(2):431. doi: 10.1016/j.eururo.2008.08.055. Epub 2008 Sep 2. Eur Urol. 2009. PMID: 18783873 No abstract available.
-
Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.Eur Urol. 2009 Feb;55(2):432. doi: 10.1016/j.eururo.2008.08.056. Epub 2008 Sep 2. Eur Urol. 2009. PMID: 18783875 No abstract available.
Similar articles
-
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial.Lancet Oncol. 2011 Sep;12(9):891-9. doi: 10.1016/S1470-2045(11)70162-0. Epub 2011 Aug 5. Lancet Oncol. 2011. PMID: 21821474 Clinical Trial.
-
Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.Eur Urol. 2009 Feb;55(2):432. doi: 10.1016/j.eururo.2008.08.056. Epub 2008 Sep 2. Eur Urol. 2009. PMID: 18783875 No abstract available.
-
Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.Eur Urol. 2009 Feb;55(2):431. doi: 10.1016/j.eururo.2008.08.055. Epub 2008 Sep 2. Eur Urol. 2009. PMID: 18783873 No abstract available.
-
The watchful waiting management option for older men with prostate cancer: state of the science.Oncol Nurs Forum. 2004 Nov 16;31(6):1057-66. doi: 10.1188/04.ONF.1057-1066. Oncol Nurs Forum. 2004. PMID: 15547629 Review.
-
Prognostic markers under watchful waiting and radical prostatectomy.Hematol Oncol Clin North Am. 2006 Aug;20(4):845-55. doi: 10.1016/j.hoc.2006.03.007. Hematol Oncol Clin North Am. 2006. PMID: 16861118 Review.
Cited by
-
Health-related quality-of-life effects of watchful waiting re-evaluated in SPCG-4.Nat Clin Pract Urol. 2009 Mar;6(3):124-5. doi: 10.1038/ncpuro1314. Epub 2009 Feb 3. Nat Clin Pract Urol. 2009. PMID: 19190593
-
Self-Management in Long-Term Prostate Cancer Survivors: A Randomized, Controlled Trial.J Clin Oncol. 2019 May 20;37(15):1326-1335. doi: 10.1200/JCO.18.01770. Epub 2019 Mar 29. J Clin Oncol. 2019. PMID: 30925126 Free PMC article. Clinical Trial.
-
Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study.Transl Behav Med. 2018 Mar 1;8(2):156-165. doi: 10.1093/tbm/ibx005. Transl Behav Med. 2018. PMID: 29425377 Free PMC article.
-
Determinants for choosing and adhering to active surveillance for localised prostate cancer: a nationwide population-based study.BMJ Open. 2019 Dec 23;9(12):e033944. doi: 10.1136/bmjopen-2019-033944. BMJ Open. 2019. PMID: 31874896 Free PMC article.
-
Intrusive thoughts and quality of life among men with prostate cancer before and three months after surgery.Health Qual Life Outcomes. 2013 Sep 11;11:154. doi: 10.1186/1477-7525-11-154. Health Qual Life Outcomes. 2013. PMID: 24025241 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials